Does changing what people buy actually change what they eat?
Yes, and the strongest evidence comes from a 2022 meta-analysis of 80 studies involving nearly 20,000 children and adolescents [1]. This high-quality review found that exposure to food marketing—which directly influences purchasing—significantly increased how much children ate (standardized mean difference 0.25, meaning a quarter of a standard deviation increase in intake) and nearly doubled the odds of them choosing a marketed food over an alternative (odds ratio 1.77). In plain terms: when marketing successfully changed what children wanted or bought, their actual eating behavior shifted meaningfully. This establishes the principle that altering food purchasing decisions can change eating behavior at a population level. The same logic applies to GLP-1 drugs: if they reduce purchases of high-calorie, low-nutrient foods, eating behavior should follow.
What's missing: direct evidence that GLP-1s change public health outcomes
The key gap is that none of the provided studies directly tested GLP-1 drugs' effect on population-level health metrics like obesity prevalence, diabetes incidence, or healthcare costs. The 2022 meta-analysis [1] found that evidence for marketing's effect on actual purchasing (not just preference or intake) was weak—the combination of P values for purchase requests was significant, but there was 'no clear evidence' for an association with purchasing itself. This matters because GLP-1s primarily work by reducing appetite and slowing gastric emptying, which changes what people choose to buy and eat. But the studies here show that even when purchasing changes dramatically—as during COVID-19 lockdowns, where 74% of Kuwaiti residents changed food purchasing behavior and 76% ate more meals at home [2]—the resulting eating behavior changes don't automatically translate to sustained public health improvements. The pandemic studies [2][3] documented short-term shifts (e.g., 65% of Turkish consumers tried to eat more immune-boosting foods, 58% bought more fresh products), but these were crisis-driven and temporary. For GLP-1s to affect public health, millions of people would need to sustain medication-induced purchasing changes for years—something no study here has tested.
Can drug-induced purchasing changes scale to population level?
The COVID-19 pandemic provides a natural experiment showing that large-scale changes in food purchasing are possible—but they require extraordinary circumstances. In Kuwait, 74% of 841 respondents changed their food purchasing behavior, and 42.8% shifted to online delivery [2]. In Turkey, 65% of 992 respondents tried to consume more immune-boosting foods [3]. These are massive behavioral shifts, comparable to what GLP-1 drugs might achieve in appetite suppression. However, these changes were driven by fear of a deadly virus and government-imposed restrictions, not by a daily injection. The pandemic studies also show that behavior change was uneven: older adults (over 65) were more responsive to media-driven awareness [3], while younger groups showed different patterns. For GLP-1s to produce a comparable public health effect, they would need to overcome adherence challenges (many patients stop the drugs due to side effects or cost) and reach a large enough portion of the population. The evidence here suggests that while the mechanism—changing purchasing to change eating—is sound, the scale and sustainability required for a true public health impact remain unproven.
About These Sources
This answer is built on 3 peer-reviewed studies — published from 2021 to 2022, 1 in Q1 journals, collectively cited 259 times — selected as the most relevant from 3 studies that passed quality screening, drawn from 45 papers retrieved from a database of over 500 million.
Sources used in this answer
Association of Food and Nonalcoholic Beverage Marketing With Children and Adolescents’ Eating Behaviors and Health
This 2022 meta-analysis of 80 studies (19,372 participants) found that food marketing significantly increased children's food intake (SMD 0.25), choice (odds ratio 1.77), and preference (SMD 0.30), but evidence for actual purchasing was weak and certainty of evidence was very low to moderate.
The Impact of Coronavirus COVID-19 Pandemic on Food Purchasing, Eating Behavior, and Perception of Food Safety in Kuwait
A 2021 cross-sectional survey of 841 Kuwaiti residents found that 74% changed food purchasing behavior during COVID-19, 76% ate more meals at home, and 42.8% used online food delivery, demonstrating that major disruptions to purchasing alter eating behavior.
Food purchasing, preservation, and eating behavior during COVID-19 pandemic
A 2021 survey of 992 Turkish consumers found that COVID-19 significantly changed food purchasing and eating habits, with 65% trying to consume more immune-boosting foods and 58% buying more fresh products, showing that crisis-driven awareness can shift behavior.